Technology | 2007.03.28
Cell Signaling Technology Announces Alliance with Merck to Provide PhosphoScan(R) Proteomics & Antibody Development for Biomarker Discovery to Support Oncology Therapeutic Programs
DANVERS, Mass.--(BUSINESS WIRE)--Cell Signaling Technology, Inc. (CST) announced today an alliance with Merck under which it will provide its patented PhosphoScan
For more information, please visit
http://home.businesswire.com/portal/site[...]=en&ndmConfigId=1001385&vnsId=
